What Researchers Did
Researchers randomized 41 athletes with exercise-related muscular injuries into either a hyperbaric oxygen therapy (HBOT) group or a control group, both receiving 10 treatment sessions.
What They Found
At the end of 10 sessions (T3), the HBOT group showed significant reductions in muscle damage markers like creatine phosphokinase, glutamic oxaloacetate transaminase, and myoglobin, which lasted until two weeks post-treatment (T4). This group also reported significant improvements in pain intensity and interference at T3, while the control group showed no statistical differences in any measured parameters.
What This Means for Canadian Patients
For Canadian athletes with exercise-related muscular injuries, hyperbaric oxygen therapy (HBOT) could potentially offer a way to accelerate recovery by reducing muscle damage and pain. This might facilitate a faster return to sport and daily activities, providing a practical treatment option.
Canadian Relevance
This study has no direct Canadian connection, as indicated by the metadata. However, its findings on HBOT for muscular injury could be relevant for Canadian sports medicine practitioners and athletes.
Study Limitations
A potential limitation is the relatively small sample size of 41 athletes, which may affect the generalizability of the results.